The Impact of Mesenchymal Stem Cell Therapy on Cognitive Performance in People Living with Multiple Sclerosis

Public Deposited
Resource Type
  • In Multiple Sclerosis (MS), cognition is directly affected by neural integrity and secondary disease characteristics (anxiety, depression and fatigue). Mesenchymal stem cell therapy (MSCT) has been recently studied due to its potential for neural repair in MS. It is hypothesized that cognitive improvement will be seen after MSCT. The change in cognition is expected to be correlated with changes in secondary disease characteristics and neurophysiological measures (neural conduction time). Ten participants received MSCT. Cognition, secondary disease characteristics, and conduction time were evaluated pre- and post- (12 month) therapy. Eight participants demonstrated cognitive improvement in at least one test. Secondary disease characteristics and conduction time were not associated with cognition in our sample. In conclusion, MSCT appears to be safe with regards to cognition and does not worsen secondary disease characteristics. Future efficacy studies have the potential to show greater cognitive improvement than the current preliminary study.

Thesis Degree Level
Thesis Degree Name
Thesis Degree Discipline
Rights Notes
  • Copyright © 2018 the author(s). Theses may be used for non-commercial research, educational, or related academic purposes only. Such uses include personal study, research, scholarship, and teaching. Theses may only be shared by linking to Carleton University Institutional Repository and no part may be used without proper attribution to the author. No part may be used for commercial purposes directly or indirectly via a for-profit platform; no adaptation or derivative works are permitted without consent from the copyright owner.
Date Created
  • 2018


In Collection: